Atlas Trials

Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection

Clinical trial NCT06734260 · RECRUITING

Trial details

NCT number
NCT06734260
Sponsor
Eighth Affiliated Hospital, Sun Yat-sen University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Helicobacter Pylori Eradication Rate
Start date
2024-09-10
Primary completion
2025-11-10
Enrollment
477

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.